BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+13.22%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$25B
AUM Growth
+$25B
(+10%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
3.39%
Top 10 Holdings %
Top 10 Hldgs %
85.68%
Holding
126
New
11
Increased
17
Reduced
63
Closed
6
Top Buys
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$437M |
| 2 |
Prelude Therapeutics
PRLD
|
$305M |
| 3 |
Kymera Therapeutics
KYMR
|
$63.3M |
| 4 |
Nurix Therapeutics
NRIX
|
$62.5M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$48.2M |
Top Sells
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$94.5M |
| 2 |
Insmed
INSM
|
$24.2M |
| 3 |
Neurocrine Biosciences
NBIX
|
$22.1M |
| 4 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$21.6M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$21.1M |
Sector Composition
| 1 | Healthcare | 97.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Adaptive Biotechnologies
ADPT
$1.96B
| $21.4M | 0.09% |
440,539
-23,000
| -5% | -$1.12M |
|
52
Novavax
NVAX
$1.2B
| $20.3M | 0.08% |
187,376
-54,000
| -22% | -$5.85M |
|
|
IMMU
53
DELISTED
Immunomedics Inc
IMMU
| $20.2M | 0.08% |
237,694
-92,306
| -28% | -$7.85M |
|
|
ALBO
54
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $18.3M | 0.07% |
549,047
+180,000
| +49% | +$6.01M |
|
55
Korro Bio
KRRO
$245M
| $18.2M | 0.07% |
949,555
+3,836
| +0.4% | +$74K |
|
56
Athira Pharma
ATHA
$15.5M
| $16.3M | 0.07% |
+882,352
| New | +$16.3M |
|
57
Xencor
XNCR
$594M
| $15.9M | 0.06% |
410,142
-17,978
| -4% | -$697K |
|
|
BLUE
58
DELISTED
bluebird bio
BLUE
| $13.6M | 0.05% |
252,000
-13,000
| -5% | -$702K |
|
59
Harmony Biosciences
HRMY
$2.16B
| $13.6M | 0.05% |
+400,000
| New | +$13.6M |
|
|
GWPH
60
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $13.5M | 0.05% |
138,745
-46,300
| -25% | -$4.51M |
|
61
Mirum Pharmaceuticals
MIRM
$3.75B
| $10.7M | 0.04% |
553,009
-30,324
| -5% | -$584K |
|
62
Immatics
IMTX
$662M
| $10.6M | 0.04% |
1,001,414
+851,414
| +568% | +$9.03M |
|
|
VXRT
63
DELISTED
Vaxart
VXRT
| $10.4M | 0.04% |
1,566,121
-73,000
| -4% | -$485K |
|
|
ACGN
64
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $9.86M | 0.04% |
4,608,786
| – | – |
|
|
UROV
65
DELISTED
Urovant Sciences Ltd.
UROV
| $9.14M | 0.04% |
978,505
-21,495
| -2% | -$201K |
|
66
Sangamo Therapeutics
SGMO
$161M
| $8.98M | 0.04% |
949,823
-50,000
| -5% | -$473K |
|
67
Xenon Pharmaceuticals
XENE
$2.99B
| $8.42M | 0.03% |
760,308
-38,794
| -5% | -$429K |
|
|
ISEE
68
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $7.93M | 0.03% |
1,406,037
-229,464
| -14% | -$1.29M |
|
69
AnaptysBio
ANAB
$630M
| $7.19M | 0.03% |
487,243
-26,434
| -5% | -$390K |
|
70
uniQure
QURE
$954M
| $7.16M | 0.03% |
194,383
-36,500
| -16% | -$1.34M |
|
71
Cabaletta Bio
CABA
$144M
| $6.9M | 0.03% |
636,363
| – | – |
|
|
HOOK
72
DELISTED
HOOKIPA Pharma
HOOK
| $6.63M | 0.03% |
700,481
| – | – |
|
|
SYRS
73
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $6.1M | 0.02% |
690,167
| – | – |
|
|
KRTX
74
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $6.01M | 0.02% |
77,776
-4,200
| -5% | -$325K |
|
|
BNR
75
Burning Rock Biotech
BNR
$85.6M
| $5.95M | 0.02% |
237,300
-12,700
| -5% | -$318K |
|